ERBB4 and schizophrenia: Hypofunction of the NMDA receptor is hypothesized to be a mechanism underlying cognitive dysfunction in individuals with schizophrenia (Pitcher et al., 2011) and altered NRG1-ErbB4 signaling may contribute to NMDA receptor hypofunction seen in these patients (Hahn et al., 2006).